[ST elevation acute coronary syndromes. Pharmaco-mechanic strategy is the universal treatment future?]

Area of Science:

• Cardiology
• Interventional Cardiology
• Emergency Medicine

Context:

• ST elevation acute myocardial infarction (STEMI) requires rapid reperfusion of the occluded artery.
• Current treatment aims to minimize myocardial damage by restoring blood flow quickly.
• Time is critical in managing STEMI to preserve heart function.

Purpose:

• To evaluate the efficacy of a pharmaco-invasive strategy for reperfusion in STEMI.
• To explore novel pharmacologic combinations for rapid artery recanalization.
• To assess the safety and feasibility of this approach, including bleeding risk.

Summary:

• The pharmaco-invasive strategy aims for rapid recanalization of the culprit artery in STEMI.
• It involves using reduced-dose fibrinolytics, potentially with IIb/IIIa inhibitors, to improve initial blood flow.
• Percutaneous coronary interventions (PCI) are planned for a later stage.
• This strategy necessitates careful bleeding risk assessment, especially in elderly patients (≥75 years).

Impact:

• This approach may reduce time to reperfusion, thereby limiting myocardial injury.
• It offers a potential alternative or adjunct to primary PCI, especially in settings with limited resources.
• Increased bleeding risk is a key consideration requiring vigilant patient monitoring and risk stratification.